Good morning, welcome to American Water's first quarter 2023 earnings conference call. As a reminder, this call is being recorded and is also being webcast with an accompanying slide presentation through the company's investor relations website. The audio webcast archive will be available for one year on American Water's investor relations website. I would now like to introduce your host for today's call, Aaron Musgrave, Vice President of Investor Relations. Mr. Musgrave, you may begin. Thank you, Betsy. Good morning, everyone. Thank you for joining us for today's call. At the end of our prepared remarks, we will open the call for your questions. Let me first go over some safe harbor language. Today we will be making forward-looking statements that represent our expectations regarding our future performance or other future events. These statements are predictions based on our current expectations, estimates, and assumptions. Since these statements deal with future events, they are subject to numerous known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from the results indicated or implied by such statements. Additional information regarding these risks, uncertainties and factors, as well as a more detailed analysis of our financials and other important information is provided in the first quarter earnings release and in our March 31st Form 10-Q, each filed yesterday with the SEC. Finally, all statements during this presentation related to earnings and earnings per share refer to diluted earnings and diluted earnings per share. Susan Hardwick, our President and CEO, will share highlights of results 2023 EPS guidance and longer-term targets and the proposed PFOS rule recently announced by the U.S. EPA. John Griffith, our Executive Vice President and CFO, will cover our first quarter financial results in more detail, discuss our successful equity issuance, We'll close with an update on sizable acquisitions announced so far this year. Cheryl Norton, our Executive Vice President and COO, will then discuss our capital investment plan and active general rate cases and conclude with a few regulatory updates, including details of the EPA's proposed PFAS rule. We'll then close by answering your questions. With that, I'll turn the call over to American Water's President and CEO, Susan Hardwick. Thanks, Aaron, good morning, everyone. As we announced yesterday, we're off to a good start in 2023 with strong financial results. As shown on slide five, earnings were $0.91 per share for the quarter compared to $0.87 per share last year. The increased results were as expected and put us on track to achieve our full-year earnings guidance, which we're pleased to affirm. Here you can also see a recap of some of our other key accomplishments so far in 2023, John and Cheryl will add to these in their remarks. As we announced in March, we completed a very successful upsized equity issuance of $1.7 billion of American Water common stock. This delivered on the highest priority in our 2023 financing plan. We also invested well over $500 million of capital in infrastructure in the quarter. In addition, we secured two large acquisitions so far this year, which puts us at over $550 million of acquisitions under agreement. We did all of this while keeping customer bills affordable and staying true to our high value of quality service. The other significant news in the first quarter for us and the water industry as a whole came from the U.S. Environmental Protection Agency when they released proposed national standards for PFAS. We support the EPA's efforts to protect drinking water quality. These contaminants are among the multiple challenges in the water industry faces regarding water quality, quantity, and reliability. We remain steadfast in our commitment to be a leader in the U.S. water and wastewater industry and a provider of solutions to these challenges. Providing safe, clean, reliable, and affordable water and wastewater service to customers has been American Water's mission for over 130 years. We will continue to work cooperatively with the EPA and with Congress, regulators, and policymakers in support of water quality standards that protect customers and communities, balanced with affordability. Cheryl will elaborate further on the PFAS proposal and our response to it, but I want to assure our customers, regulators, investors, and other stakeholders that American Water has the expertise and the will to tackle this issue head on and to advocate for reasonable policies and outcomes related to this very important topic. Turning to slide six. As I mentioned, we are affirming our 2023 EPS guidance range of $4.72-$4.82 per share, as well as our long-term targets. We believe our strong regulatory and operational execution is a positive differentiator from our peers. As we've done in the past, we expect to consistently deliver on our annual and long-term plans, growing earnings and dividends at a top-tier pace over the next five years and beyond. Moving on to slide seven. As we announced yesterday, our board of directors increased the company's quarterly cash dividend from $0.655 per share to $0.7075 quarter per share, an 8% increase. We have grown our dividend at a compounded annual growth rate of 9.7% over the last five years, significantly outpacing most of our utility peers. Looking ahead, we continue to expect to grow our dividend at 7%-9% per year on average, which is in line with our compelling 7%-9% EPS growth target. Our board and management team understand and appreciate how important the dividend component of our total shareholder return is to many of our investors. With that, let me turn it over to John to cover some first quarter highlights and financial results in more detail. John? Thank you, Susan. Good morning, everyone. Turning to slide nine, I'll start by reviewing the equity issuance completed in March, really the first primary offering of meaningful size for American Water since 2009. As we've said, our plan was to issue in 2023 a significant portion of the $2 billion of expected equity needed in our current five-year plan that goes through 2027. We were pleased to see very strong demand for the offering, which was upsized, and the greenshoe fully exercised for proceeds of $1.7 billion. The remaining portion of the $2 billion of our currently planned equity is expected to be issued near the end of this five-year plan. We used some proceeds to bring our commercial paper balance down to 0 by quarter end with a modest amount of cash left over. With the equity issuance, our balance sheet is fortified to fund our robust water and wastewater investment well into the future. Our total debt to capital ratio, which at year-end was just above our target of 60% or less, has decreased meaningfully to 54% as of quarter end. With our growth plan, this metric will rise somewhat over the next few years until we reset again, as we receive in late 2026 the note proceeds from our sale of HOS and issue the remaining equity that is in our current five-year plan. To wrap up on equity, we believe the execution of this issuance is another indicator that the American Water investment thesis is strong, led by our compelling growth story and the leadership role we play in the utility sector. I'd like to take a moment to thank our treasury, legal, IR, and many other teams at American Water, as well as our external advisors who worked diligently to prepare us to be ready to execute this transaction early in the year when the window of opportunity emerged. Turning our attention to slide 10, I'll provide some further insights into our financial results for the quarter. Earnings were $0.91 per share for the quarter, up $0.04 per share versus the same period in 2022. As you know, we have completed rate cases recently in our larger states and are seeing the increased revenues as a result. These additional revenues are driven by the significant investments we are making in our infrastructure, including the acceleration of spend made possible by the proceeds from the sales of New York American Water and Homeowner Services. As we've said consistently since the sales, it takes time to reinvest the sales proceeds. We are beginning to see those impacts. In looking at operating costs, higher pension expense of about $0.03 per share and inflationary pressure on chemical, fuel, and power costs of about $0.04 per share were largely mitigated by the higher revenues. Our proactive strategy last year to seek rate case recovery in many of our large jurisdictions of rising production costs and expected higher pension costs has positioned us favorably to limit the bottom line impact of those higher costs in 2023. As with the rate case we just filed in Indiana, we will be looking to recover higher operating costs in other jurisdictions over the next year though earning a full return on rate-based investments and acquisitions continues to be the key driver of our general rate cases. Depreciation increased $0.06 per share and interest on additional long-term debt increased $0.04 per share due to the $800 million senior note issuance from last May, both supporting our investment growth. Interest expense in the quarter also reflected about $0.04 per share from higher short-term interest rates. I would also note that the EPS impact of the higher share count from our equity issuance was essentially neutral to EPS when considering the avoided interest cost in the first quarter by paying off commercial paper. We expect dilution from the higher share count net of avoided interest expense to be approximately neutral to EPS for the full year as well. Other net consists primarily of favorable post-close adjustments recorded in the first quarter of 2022 from the sale of HOS and additional earnings in 2023 from our new Military Services Group contract with Naval Station Mayport in Florida that we were awarded last summer. Turning to slide 11, you'll see that we are set up for strong growth through acquisitions in 2023 and beyond. We had 27 transactions under agreement across nine states through the end of March, including the Butler Area Sewer Authority wastewater system in Pennsylvania we previously announced, as well as the Towamencin Township wastewater system in Pennsylvania we are purchasing for $104 million, as announced in March, as part of an agreement to assume that asset purchase agreement from NextEra. Just a few weeks ago, we were pleased to announce the purchase of the wastewater treatment plant in Granite City, Illinois, for $83 million, which puts us at over $550 million of acquisitions under contract. We hope to close on Granite City by the end of 2023 and expect to close on Towamencin by mid-year 2024, both pending regulatory approval. We look forward to serving those customers. Of course, as we close on transactions, the work to build and refill the acquisition pipeline is continuous across our footprint. Our pipeline of over 1.3 million customer connections is a strong leading indicator that supports this piece of our earnings growth triangle. Before I turn it over to Cheryl, I'll echo Susan's comment that we're off to a very good start to the year. I'm confident in our ability to achieve our 2023 EPS guidance of $4.72-$4.82 per share. Looking ahead, I am pleased that we have the right fundamentals in place, including our newly strengthened balance sheet, to achieve our long-term financial targets, which we are also affirming today. With that, I'll turn it over to Cheryl to talk more about our capital investment rate case and other regulatory updates. Cheryl? Thanks, John. Good morning, everyone. Slide 13 shows that our state and corporate leaders and their teams did a great job in the first quarter executing on our increased capital plan. It required significant effort to safely and efficiently deliver the dozens of projects that improved our systems and drove capital investment higher by nearly $100 million in the quarter compared to the same period last year. This result keeps us on pace to hit our goal of approximately $2.9 billion of capital investment spending in 2023. To show the magnitude of our regulatory execution efforts in timely recovery of these investments, you can see on slide 14 that we already have $279 million in annualized new revenues and rates since January of 2023. This includes $229 million from general rate cases and step increases, and $50 million from infrastructure surcharges. We also have $144 million of total annualized revenue requests pending, including two infrastructure surcharge proceedings. Moving on to our regulatory strategy on slide 15. Our theme here is around timely, consistent recovery of investments and operating costs. We have consistently engaged with policymakers and regulators to find the best ways to invest in water and wastewater infrastructure and achieve timely recovery. When we achieve timely and consistent recovery, it levels out bill increases to our customers, making those bills more manageable. The pie chart on the right side of the page also speaks to timely recovery of our investments across our footprint. Through capital recovery mechanisms and forward test years, we can reduce regulatory lag and lessen the reliance on general rate cases. This enables us not only to earn our allowed return, but also to mitigate the size of general rate increases for our customers. We expect about 75% of capital investments over the next five years to be recoverable through infrastructure mechanisms and through the use of forward test years, which is the key to unlocking a more consistent annual earnings growth pattern for the long term. The ability to execute our regulatory strategies is a critical success factor for continuing to grow our business each year. As water and wastewater industry challenges grow, we'll continue to focus on constructive regulatory and legislative outcomes to help us work through those challenges. Let's go to slide 16 and cover the latest regulatory activity in our states. Shown on the slide is a summary of our pending general rate cases with some key facts for each. In the appendix, you'll also find some details related to infrastructure charges, as well as a snapshot of the key outcomes from the most recent general rate cases in our top 10 states. At the end of March, we filed a general rate case in Indiana reflecting $875 million in water and wastewater system investments to be made through 2025 to continue providing safe and reliable service. The revenue request also includes an increase in the cost of chemicals and other operating costs that we continue to see. We are seeking to increase revenues over a phased three-step process through May 2025 that would result in $87 million of additional annual revenue when fully implemented. In California, our case was filed in July of last year and is progressing as expected so far. We're seeking increased revenues of approximately $95 million over a phased three-step process with rate changes expected to be effective in 2024, 2025, and 2026. We're also still awaiting a ruling from the Commission on the pending cost of capital case. In Missouri, on March 3rd, we were pleased to file a settlement agreement with the Missouri Public Service Commission. The settlement reflects an increase of $95 million in annualized revenues, including $51 million for previously approved infrastructure surcharges. A final decision on this matter is expected in the second quarter of 2023. Finally, earlier this week, the Virginia State Corporation Commission approved the settlement of our rate request, authorizing a total annualized revenue increase of approximately $11 million. Outside of general rate cases, there were a few notable developments since our fourth quarter 2022 call. In California, related to the Monterey Water Supply Project, we signed the Pure Water Monterey Expansion Agreement following an order issued by the CPUC. We are now allowed to standard ratemaking treatment for the construction funding of the pumps and pipes that were built to support the expansion. Together with the desalination and water reuse projects in process and aquifer storage and recovery online, we believe that a secure water future for the Monterey Peninsula is now possible once the approval process is complete. On the legislative front in Indiana, Senate Bill 180 passed the State House and Senate with bipartisan support and is awaiting the governor's signature where it will become effective immediately. This bill allows for consolidated rates and wastewater systems through Indiana's Service Enhancement Improvement Rider. Turning to PFAS, I'll expand on Susan's earlier comments on EPA's proposed rulemaking. While American Water has long been anticipating and preparing for the rulemaking, our initial analyses were primarily based on a federal PFAS standard that would be more in line with the higher treatment limits set by several states. We are carefully reviewing the EPA's proposed drinking water regulation to assess the four parts per trillion limits for PFOA and PFOS and the application of the Hazard Index approach for several other chemicals. Our review will assess impacts to our capital and operating expense plan as well as our needed financing. It's logical to assume that the significantly lower treatment level, the number of facilities that will require treatment will be larger, as will the costs. One of our early concerns is that EPA's cost estimates are materially understated. Our analysis continues. Upon completion of our preliminary assessment, we'll submit comments on the proposal to the EPA by May thirtieth. As the EPA develops its final rule, which is expected by the end of 2023, we'll have more information to share based upon further review and analysis. To be very clear, though, American Water joins other water organizations in support of the EPA, Congress, and other decision-makers in implementing reasonable policies aimed at keeping harmful PFAS out of drinking water supplies and communities. In addition to the comments we intend to provide on the proposed rule itself, we also expect to provide comments to the EPA and others on many related issues, including the following. We'll ask for an exemption of water and wastewater systems from financial liability for PFAS under CERCL. We'll also ask to ensure all water and wastewater utility providers, regardless of ownership, have equal access to any and all federal and/or state funding related to treating PFAS. In addition, we'll request permanent federal funding for a water and wastewater low-income customer assistance program. Providing safe, reliable, and affordable water is American Water's business. We'll continue to work productively with the EPA, Congress, regulators, and policymakers to ensure that the implementation of any final standards protect customers, communities, and the general public. With that, I'll turn it back over to our operator to begin Q&A and take any questions you might have. We will now begin the question-and-answer session. To ask a question, you may press star then 1 on a touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, please press star then two. At this time, we will pause momentarily to assemble our roster. The first question today comes from Richard Sunderland with JP Morgan. Please go ahead. Hi, good morning. Thank you for the time today. Appreciate all the commentary on the PFAS side, but just wanted to dig in there a little bit more. Any way to frame the magnitude of capital versus O&M that's particularly, you know, particularly levered to an outcome here? You know, at a minimum, is this more of a capital opportunity than an expense concern or you're kind of flagging both as, you know, potential impacts to rates on a go-forward basis? Good morning, Rich. Yeah, it's a great question. Obviously, as Cheryl indicated, we have a lot of analysis to do with this proposed rule, at these treatment limits that are proposed. You know, Rich, how this works, I mean, there's a process to be worked here in terms of comments and feedback to the EPA about the proposed rule. As Cheryl said, obviously we're quite supportive of what they're trying to accomplish here. In fact, even at the four parts per trillion, we don't have huge issue with that. I think the issue is around cost. As Cheryl said, you know, our early expectations here are that the EPA estimates around costs are understated. I think that'll be part of the response that the industry generally provides back to the EPA. For us, we're, as I said and Cheryl said, we're continuing to evaluate the impacts. As you know, we've talked about this many times, we use a risk-based approach to our capital planning. As we work these projects into our capital plan, you know, it could very well change that risk profile and move other projects out. As we think about changes to our overall plan, we've still got a lot of work to do to determine that. Specific to your question, though, around capital versus O&M, we think there's a, you know, a fair amount of both that will be necessary at this level. There'll be capital requirements to have facilities that are able to facilitate the treatment. Of course, there'll be an ongoing operating cost associated with the treatment itself. lots to be learned yet on this, and again, direct impacts to our plan yet to be determined. Okay, understood. That's very helpful context. I guess sticking with the cost side, you know, we spent a lot of time last year discussing chemicals costs, and it came up in the, in the walk this year in terms of the rate recovery of those higher costs. Can you speak a little bit more to the recent trends you're seeing there and maybe bridge that back to your expectations last fall when you laid out the latest plan? How do you think about these expenses impacting customer bills over the next few years? Yeah, Richard, good question, and Cheryl and John certainly can weigh in on this too. We have seen, I'd say, a continuation of the impacts that we started seeing, you know, really in the second quarter of last year. While some of the increases in certain costs may have started to level out a bit, they still are all elevated, and we expect that to continue for some time. I think the real key here, and you touched on it, is the work we did in the regulatory arena to address these costs early on. And we've estimated that roughly 75% of the costs we'll experience in 23, we've got fully baked into rates as a result of those cases we did last year. As Cheryl mentioned, or maybe John did in the prepared remarks, in the Indiana case we just filed, we've addressed it there too. We think we have done as good a job as could be done to address these costs early on so that they don't have bottom line impact. We continue to see, you know, a fair amount of pressure here on the cost side. Okay, great. I appreciate all the detail there as well. Thank you for the time today. Sure. Thanks, Rich. The next question comes from Angie Storozynski with Seaport. Please go ahead. Thank you. First maybe like, the presentation question. You no longer show us the breakdown of earnings by segment, right? There's no bridge, for regulated earnings, market base and corporate. Can you give us this breakdown for the quarter? Well, I think the waterfall that you have there, probably is as good as there is. You know, the impact from the market-based business, which is now just military, is very small, and on a year-over-year basis, just not much of a variation. The other segment, I think we highlighted the primary driver there, which would have been the gain, the sort of true up gain on the HOS sale, in the first quarter of last year. If I mean, I tried to actually apply it from the 10-Q, and I couldn't, anyway. Moving on to, you did mention the weather as a factor in earnings, and that's, I think, something that we've seen on the electric side and a couple of your water peers have also, you know, highlighted as a drag on the quarter. Was that a driver at all? Yeah, first quarter for us is not much of a weather, impact year. Cheryl, you wanna just talk about seasonality or? Yeah. You know, our biggest weather impacts are gonna be in second and third quarter. Sometimes it will spill over into the fourth quarter. Typically, the first quarter, unless the weather is really, really severe in one direction or another, we won't see any weather impact at all. This year, I think the weather was not that dramatic for us to see that impact, I think we're pretty solid. Okay. Lastly, I noticed that you are pursuing an appeal of that denial of the acquisition adjustment related to the Shorelands acquisition. It looks like a decision will be issued sometime in 2023. Can you... Again, I haven't followed it closely, but can you give us a sense of is this still a long shot? I mean, how important is it for any future growth aspirations you might have? I know that that transaction itself is only $29 million, so that's not that big a deal as far as the goodwill impact. Again, any implications related to this pending case? Yeah. Really no no implications of any materiality. Cheryl, you wanna comment on status here? Yeah. Angie, it's. Yeah, the issue is still kind of hanging out there, but there's gonna be no real impact to us from a financial perspective. In all honesty, we found other ways of doing deals so that we're not so worried about the precedents that this decision sets for us. We still believe like we have a strong case, but in the grand scheme of things, it really has little to no impact. Okay. Just going back to PFAS, I'm sorry. I looked at these rules, you know, pretty strict requirements, with penalties. I think that the problem we've seen over the last, I think couple of decades is that EPA hasn't been really, in, you know, imposing those penalties or, really, you know, going after the systems that have been noncompliant with the regulations. I'm just wondering how big a difference would there be with this one as far as, for example, your, you know, municipal M&A or any sort of additional pressure that that should exert on privately or municipally owned systems? Again, because EPA hasn't been, you know, particularly diligent in imposing other rules. Yeah, I think it's a fair observation, Angie i t's obviously one of the things that we'll address in our comments. We think that these rules should apply obviously to all providers, and that EPA should use its authority to enforce the rules. There is a track record here. We'll have to again sort of comment on that. As it relates to our views on acquisition potential, John, you wanna comment on that? We think there could be some opportunity, but I think you've hit on the key issue. Yes. Angie, I'd just say that we look at this issue as another reason on the list for why municipals may choose to sell to us in the future. Okay. Thank you. Thanks, Angie. The next question comes from Paul Zimbardo with Bank of America. Please go ahead. Hi. Good morning, team. Morning. Congrats on the successful equity offering. Just curious, did you consider placing the full $2 billion of equity for the full plan to just take it out of the way, given the strong demand? I believe I heard you say that you expect the equity offering to be EPS neutral on full year 2023 versus plan. Was that correct? John, you wanna comment here? Sure. Yeah. On the first part of the question, we tried to remain consistent with the messaging that we had provided to investors in the past. As we thought about the magnitude of the issuance, we wanted to stay within that range and we did so. With regards to dilution, that's correct. We expect that, just given our ability to pay off debt and with where interest rates are and given how we trade from a valuation perspective, we look at the issuance as EPS neutral. Okay. Great. Switching topics, I noticed that Indiana legislation as well, does that influence higher any of the prospective capital or acquisition priorities in the state? John, you wanna comment on that? This is, yeah, the question really, Paul, is around this consolidated rate issue, that legislation you're referring to. Well, the additional mechanism from the new legislation that was enacted. It seems like it could help reduce regulatory lag perspectively. Yeah, I think that's probably fair, and I do think it probably creates opportunity around acquisitions. Again, I think it gives us more leverage to grow in Indiana and use that consolidated revenue mechanism to lessen the bill impact on customers. I think it's a very important piece of legislation from that perspective to again, sort of facilitate growth. Okay, great. Thank you, team. Appreciate it. All right. Thanks, Paul. The next question comes from Gregg Orrill with UBS. Please go ahead. Yeah, thank you. Congratulations. Morning, Greg. Good morning. I was wondering if I could ask your view on sort of Florida as a market for acquisitions. I think there's legislation that's progressing there on fair value. Then just how you're thinking about the pursuit of litigation regarding the PFAS rules to, you know, help pay and sort of the how that would get folded in versus the timeline for compliance. Thank you. Those are two big topics, Greg. First, maybe on Florida, let me just comment there. I think, obviously we're following developments there, as we do sort of across the nation, around legislative actions, regulatory actions, et cetera. I'd say our answer is the same as it always is on potential growth into other states. If we really have to see an opportunity to grow substantially in a particular state, we look at regulatory environment, legislative environment, those types of things. We're constantly looking at opportunities. All of the parts have to sort of come together, I think, for us to do anything significant beyond our existing footprint. Of course we like a lot. We think we have optimized our footprint. We like the environments that we're in. We have great opportunities for growth in our existing jurisdictions, obviously that's where our focus continues to be. On your second question around PFAS and litigation and impacts there, as Cheryl mentioned, there is litigation and has been for some time around this. Our goal here, I think the industry's goal is to, well, while we feel responsible for helping to solve the problem and we're best positioned to do the treatment, we do think it's important that those that are responsible for the production of the chemicals also be held responsible. Our states are actively involved in that litigation, will continue to be. We do think that's an important part of this overall equation that has to be worked through. Again, customer affordability is at the heart of that. We don't think it's necessary or appropriate for customers to pay for things that, you know, they really aren't responsible for. We'll be actively pursuing that litigation along with the rest of the industry. Okay. Thanks for your comments. Sure. Thank you. As a reminder, if you have a question, please press Star, then one to be joined into the question queue. The next question comes from Jonathan Reeder with Wells Fargo. Please go ahead. Hey, good morning, team. I just wanted to build a little bit on Angie's earlier question, just regarding kind of the segment breakdown a little bit. Can you give us some directional guidance? I don't think your full year was exactly broken out by the two segments and with kind of other being recast to include, you know, what's left of market based and the, you know, other historical parent and other segment. I think full year 2022 was $0.19 from that segment, but that included, I think it was a $19 million pre-tax gain. How should we be thinking about, I guess, full year 2023 kinda overall drag there? Boy, Jonathan, we're gonna have to go back and look at those numbers. Those numbers don't sound right to me for the prior year. You know, we had some true up activity related to the HOS sale, you know, and maybe that's getting confused a bit here, but all that's remaining is our Military Services Group. You know, the earnings year-over-year really not much of a variance. It's a relatively small part of the overall earnings contribution anyway. We can follow back up on that reconciliation, the numbers that you're quoting, 'cause again, I don't think that's reflective of the size of the business. I mean, it sounds like if we just strip out maybe that $19 million pre-tax true up gain or whatever, that you're kind of thinking the other part of the business is kind of flattish when we look at it from, 2022 to 2023. Yeah, certainly the Military Services Group operations year-over-year, relatively flat. We'll need to verify that $19 million pre-tax number you're quoting there. That doesn't ring a bell to me. I mean, I know there's a number there. I just don't recall it being that. We'll have Aaron follow back up with you on that just to make sure we got the right numbers there. Okay. All right. Great. Thanks. I appreciate it. Sure. No problem. This concludes our question and answer session and concludes the conference call. Thank you for attending today's presentation. You may now disconnect.